0001171843-23-004119.txt : 20230626 0001171843-23-004119.hdr.sgml : 20230626 20230626165400 ACCESSION NUMBER: 0001171843-23-004119 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230619 FILED AS OF DATE: 20230626 DATE AS OF CHANGE: 20230626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nunes Anne CENTRAL INDEX KEY: 0001982862 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14027 FILM NUMBER: 231042985 MAIL ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anika Therapeutics, Inc. CENTRAL INDEX KEY: 0000898437 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043145961 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: (781) 457-9000 MAIL ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC DATE OF NAME CHANGE: 19970114 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA RESEARCH INC DATE OF NAME CHANGE: 19930309 3 1 ownership.xml X0206 3 2023-06-19 0 0000898437 Anika Therapeutics, Inc. ANIK 0001982862 Nunes Anne 32 WIGGINS AVENUE BEDFORD MA 01730 0 1 0 0 SVP, Chief Operations Officer Common Stock 3293 D Restricted Stock Unit 0 Common Stock 4982 D Stock Option (Right to Buy) 43.27 2031-10-01 Common Stock 8640 D Stock Option (Right to Buy) 47.60 2031-10-01 Common Stock 9225 D Restricted Stock Unit 0 Common Stock 5122 D Stock Option (Right to Buy) 28.14 2032-03-11 Common Stock 8763 D Restricted Stock Unit 0 Common Stock 9886 D Stock Option (Right to Buy) 29.60 2033-03-09 Common Stock 10629 D Each RSU represents the contingent right to receive one share of the Company's common stock. 7,473 RSUs were granted on October 1, 2021 and the RSUs vest in three equal annual installments beginning October 1, 2022. The stock options vest in three equal annual installments beginning on October 1, 2022. Represents a 10% premium above the closing price of Anika's common stock on the date of grant. Each RSU represents the contingent right to receive one share of the Company's common stock. 7,683 RSUs were granted on March 11, 2022 and the RSUs vest in three equal annual installments beginning March 11, 2023. The stock options vest in three equal annual installments beginning on March 11, 2023. Each RSU represents the contingent right to receive one share of the Company's common stock. 9,886 RSUs were granted on March 9, 2023 and the RSUs vest in three equal annual installments beginning March 9, 2024. The stock options vest in three equal annual installments beginning on March 9, 2024. /s/ Anne Nunes 2023-06-26